Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AQST compared with AZN: revenue, margins and what each company keeps, and the suppliers and customers both name
AQST
Aquestive Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AZN
Astrazeneca PLC
Change
Mkt cap
Revenue
Revenue
vs
Compare
AQST
Aquestive Therapeutics, Inc.
vs
AZN
Astrazeneca PLC
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
AQST
Aquestive Therapeutics, Inc.
Change
3.89
▼
−3.79%
· post 3.92
Mkt cap
$488.2M
Revenue
$14M
Q2 FY26
Revenue
$45M
FY25
AZN
Astrazeneca PLC
Change
186.63
▲
+7.01%
· post 186.35
Closed
Oct 30 '26
Mkt cap
$289.5B
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
AQST
Aquestive Therapeutics, Inc.
vs
AZN
Astrazeneca PLC
3.89
▼
−3.79%
post 3.92
Price
186.63
▲
+7.01%
post 186.35
$488.2M
Mkt cap
$289.5B
Q2 FY26
$14M
Revenue
—
FY25
$45M
Revenue
—
Change
Change
AQST
3.89
▼
−3.79%
vs
AZN
186.63
▲
+7.01%
Closed
Oct 30 '26
Earnings history
last 4 reports each · paired by recency
Method
›
AQST
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±12.4%
▼
−4.08%
×0.33
May 14 '26
±7.7%
▲
+14.53%
×1.88
Q1 FY26
±14.1%
▼
−2.52%
×0.18
Q3 FY25
±16.2%
▲
+2.17%
×0.14
AZN
No earnings history for AZN.
= implied
AQST realized, solid
AZN realized, hatched
One scale, both sides: full bar = 17%
× = |realized| ÷ implied
Source: market data